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Abstract
Background: Preoperative staging of cervical lymph nodes is important to determine the extent of neck dissection in
patients with oral squamous cell carcinoma (OSCC).
Purpose: To evaluate whether a preoperative discrimination of benign and malignant cervical lymph nodes with
diffusion-weighted imaging (DWI) (3T) is feasible for clinical application.
Material and Methods: Forty-five patients with histological proven OSCC underwent preoperative 3T-MRI. DWI
(b¼ 0, 500, and 1000 s/mm2) was added to the standard magnetic resonance imaging (MRI) protocol. Mean apparent
diffusion coefficients (ADCmean) were measured for lymph nodes with 3mm or more in short axis by two independent
readers. Finally, these results were matched with histology.
Results: Mean ADC was significantly higher for malignant than for benign nodes (1.143 0.188 * 103 mm2/s vs.
0.987 0.215 * 103 mm2/s). Using an ADC value of 0.994 * 103 mm2/s as threshold results in a sensitivity of 80%,
specificity of 65%, positive predictive value of 31%, and negative predictive value of 93%.
Conclusion: Due to a limited sensitivity and specificity DWI alone is not suitable to reliably discriminate benign from
malignant cervical lymph nodes in daily clinical routine. Hence, the preoperative determination of the extent of neck
dissection on the basis of ADC measurements is not meaningful.
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Introduction
In the past, local surgical therapy of oral squamous cell
carcinoma (OSCC) with cervical metastases was always
accompanied by radical neck dissection, which was
often associated with great postoperative morbidity
(1). Today the selective supraomohyoid neck dissection
(lymph node levels I–III) and modiﬁed radical neck dis-
section have replaced this radical treatment strategy as
there is strong clinical evidence that they lead to the
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same oncologic results with less postoperative morbid-
ity (2–4). Since the number of negative elective neck
dissections could still be up to 80%, an even more
restricted type of dissection, the so-called superselective
neck dissection, was proposed. This technique is
expected to further reduce the postoperative morbidity
without compromising oncological outcomes (5). An
important precondition for this surgical technique is a
highly sensitive and speciﬁc imaging method which
allows a reliable preoperative staging of the neck in
order to determine the necessary extent of neck dissec-
tion. Clinical examination, B-mode ultrasound, and
computed tomography (CT) do not provide the
required sensitivity and speciﬁcity and are therefore
not suited for surgical planning in terms of the extent
of lymph node dissection (6–8). PET/CT cannot be
used to modify the indication of elective neck dissection
as PET/CT is not suﬃciently sensitive for micrometas-
tases (9–11).
Diﬀusion-weighted imaging (DWI), initially intro-
duced for the detection of cerebral ischemia, is the
most frequently researched functional magnetic reson-
ance imaging (MRI) tool of the past few years. DWI
derives its contrast from the (indirect) measurement of
the Brownian motion. Varying grades of mobility of
water molecules within diﬀerent types of tissues lead
to signal changes in DWI and changes in the quantita-
tive measure of diﬀusion, the apparent diﬀusion coeﬃ-
cient (ADC). ADC has also been shown to correlate to
tissue cell density, with highly dense tissues having a
low ADC (12). Therefore, DWI has shown to be an
appropriate method to depict lymph nodes (13,14).
Whether DWI is suitable to reliably diﬀerentiate malig-
nant and benign lymph nodes is subject of investiga-
tions and controversy. If tumor cells invade the lymph
node tissue a decrease in diﬀusion is conceivable, pos-
sibly resulting in signal alteration in ADC. Regarding
the eﬃciency of diﬀerentiating malignant and benign
lymph nodes the results do diverge. With this histo-
logical matched study we aim to evaluate whether a
preoperative discrimination of benign and malignant
cervical lymph nodes with DWI using a 3T MRI
is feasible, in particular with regard to clinical
practicability.
Material and Methods
Patients
Fifty-one patients (31 men, 20 women; median age,
62 years; range, 47–82 years) with histological proven
OSCC were included in this prospective study after
they gave their written informed consent. Six patients
were excluded due to poor MR image quality. The
study was approved by the local ethic committee
(vote: 12-101-0198). Inclusion criteria were: (i) histolo-
gically proven OSCC; and (ii) treatment consisting of
surgery including superselective neck dissection.
MRI
Imaging was performed with a 3.0 Tesla MR unit
(Skyra; Siemens Healthcare, Erlangen, Germany)
using a 24-channel head/neck array coil. For anatom-
ical purpose a T2-weighted (T2W) fast spin-echo (FSE)
sequence and a T1-weighted (T1W) turbo spin-echo
(TSE) sequence were acquired in axial plane before
(T2 and T1) and after contrast medium injection
(only T1). Additionally, an axial diﬀusion-weighted
sequence in the same plane was performed for
study purpose before contrast medium application.
Sequence parameters are listed in Table 1.
ADC analyses
ADC maps were automatically generated by the MR
system using all b-values (NUMARIS/4, Syngo MR
D13, Siemens Healthcare).
The analyses were performed by two radiologists,
with 5 and 20 years of experience in head and neck
imaging. Radiologists, surgeons, and pathologist were
blinded to the ﬁndings of the other observers. All
lymph nodes located in the levels I–IIa/b on both
sides with short axes of 3mm or more were selected
in the DWI (b¼ 1000 s/mm2). These neck levels contain
helpful anatomical structures as salivary glands and
diﬀerent muscles, simplifying the correct topographical
matching between the MR images and the pathological
specimen. For the calculation of the mean ADC
(ADCmean) a polygonal ROI was drawn free-handed
around each subcentimeter and solid supracentimeter
lymph node on the b1000 images.
In case of obvious necrotic portion within a lymph
node, determined as a hyperintense region on the T2W
and hypointense region on T1W images, this area was
excluded from the ROI as seen in Fig. 1. The correct
anatomic placements of the ROIs were veriﬁed linking
the transverse T2 TSE sequence with the b1000 images.
Linking also the ADC map with the b1000 images by
slice position, the ROIs could simply be transferred to
the referring ADC map by copying the ROIs and
inserting them again in the ADC map.
Histological correlation
During surgery lymph nodes were dissected systematic-
ally level-by-level with the adjacent reference structures
as muscles and salivary glands analogue to the system
devised by the American Joint Committee on Cancer
(15). Each lymph node level specimen was pinned on a
940 Acta Radiologica 57(8)
cork board separately, with ﬁlaments anatomically
marked. The fresh specimens were then transported to
the pathology department. Each lymph node was care-
fully delineated and its short axis was measured.
Thereafter, the lymph nodes were separately put into
cassettes for further detailed histological workup.
Residual fatty tissue was submersed in formol to
detect very small lymph nodes that might have been
overlooked. Finally, lymph nodes were ﬁxed, sectioned,
hematoxylin-eosin stained, and examined microscopic-
ally with regard to tumor inﬁltration.
Recording the maximum short axial diameter, the
positional relation to the marking ﬁlaments and the
exact anatomic location of each lymph node per level
(related to adjacent anatomic structures such as mus-
cles, veins, and salivary glands) a topographic correl-
ation between the MR images and the pathological
specimen was possible for each lymph node.
Statistical analyses
Statistical analyses were performed using the stat-
istic computing environment R (version 2.15,
R Foundation for Statistical Computing). In order to
compare the ADC of benign and malignant nodes a
two-sided Student’s t-test was performed. Receiver-
operating characteristic (ROC) curve analyses were
Table 1. Sequence parameters of the diffusion-weighted image.
Parameter
Sequence type Spin-echo echo-planar
imaging
Field of view (mm) 230
Matrix 144 144
Voxel size (mm3) 1.6 1.6 3.0
Slice thickness (mm) 3
Intersection gap (mm) 0.3
Slices (n) 35
Repetition time (ms)/Echo time (ms) 8200/76
Averages (n) 4
Type of fat saturation SPAIR
B values (s/mm2) 0, 500, 1000
Acquisition time (min) 4.16
Fig. 1. Example of ROI placement for the ADC measurement of cervical lymph nodes. Axial (a) T2W and (b) T1W images are used to
verify the correct matching between lymph nodes and diffusion-weighted images. (c) The region of interest is drawn around a lymph
node metastasis on b1000 image, sparing a region suspect for necrosis (white arrow) and (d) afterwards copied on the corresponding
ADC map.
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performed to evaluate the diagnostic performance for
the diﬀerentiation of metastatic nodes based on ADC
of the nodes. Sensitivity, speciﬁcity, positive and nega-
tive predictive value, and the area under the ROC curve
(AUC) were calculated. Threshold values were deter-
mined according to the point nearest to the upper left
corner in the ROC curves. Inter-observer agreement for
the nodal ADC measurement was analyzed by calculat-
ing the intra-class correlation coeﬃcient and by using
the method of Bland and Altman.
Results
Histopathology
Of the 45 patients included in the study 26 had a pN0
status, eight a pN1 status, and 11 a pN2 status at hist-
ology. A total of 389 lymph nodes were found within
the histological specimens. A node-by-node matching
of histology and MRI was performed in 149 lymph
nodes, which presented with a short axis diameter of
3mm or more. Of these 149 nodes 25 were malignant
and 124 benign. The mean axial diameter (short axis) of
the benign lymph nodes was 5.3mm (range, 3–12mm;
standard deviation, 1.6mm) while the mean axial diam-
eter of the malignant lymph nodes was 11.0mm (range,
4–27mm; standard deviation, 5.9mm). Table 2 shows
the distribution of the benign and malignant lymph
nodes with regard to the size of the short axis. In the
group of malignant lymph nodes 11 showed necrotic
portions, seven in the group of lymph nodes with
over 10mm in short axis, and four with 6–10mm in
short axis.
ADC analyses
The mean ADCs (mean values of the two observers)
were 0.987 0.215 * 103mm2/s (range, 0.550–
1.712 * 103mm2/s, median 0.943 * 103mm2/s) for the
benign lymph nodes and 1.143 0.188 * 103mm2/s
(range, 0.855–1.603 * 103mm2/s, median 1.123 *
103mm2/s) for the malignant lymph nodes. The diﬀer-
ence between ADC values for malignant lymph nodes
and benign lymph nodes was found to be signiﬁcant
(P¼ 0.0007). The area under the curve for the detection
of metastatic lymph nodes using the mean ADC values
was 0.73 (95% CI, 0.64–0.82). The ROC curve is dis-
played in Fig. 2. A mean ADC value of
0.994 * 103mm2/s was found to be the optimal thresh-
old, resulting in a sensitivity of 80% (95% CI, 64–92%),
speciﬁcity of 65% (95%CI, 56–73%), positive predictive
value of 31%, and negative predictive value of 93%.
Fig. 3 depicts the distributions of the mean ADC of
the two observers for the benign and malignant lymph
nodes together with the found optimal threshold value.
The Bland-Altman plot for the inter-observer agree-
ment for the nodal ADCmean measurements is given in
Fig. 4. The mean absolute diﬀerence (bias) in ADCmean
values between the two readers was 6.3 * 106 mm2/s
(95% CI, 84.5 * 106mm2/s to 97.0 * 106mm2/s.)
and the intra-class correlation coeﬃcient for the nodal
ADCmean measurements was 0.97.
Discussion
The aim of our study was to judge whether diﬀusion-
weighted images could be used to diﬀerentiate malig-
nant from benign cervical lymph nodes with the intent
to preoperatively determine the extent of neck dissec-
tion in patients with OSCC. In concordance with pre-
viously published studies we observed a statistical
signiﬁcant diﬀerence in the mean ADC values of
benign and malignant lymph nodes with malignant
lymph nodes (unexpectedly) presenting with higher
ADC values than benign ones (Figs 5 and 6).
Nonetheless, our results indicate that diﬀusion-
weighted MRI is not accurate enough for surgical plan-
ning of neck dissections due to the overlap of ADC
value distributions of benign and malignant lymph
nodes (Fig. 3).
In 2013 Heijnen et al. came to a similar result after
they examined 102 lymph nodes in the small bowel of
21 patients with primary rectal cancer. They found
higher ADC values for malignant than for benign
lymph nodes (1.15 0.24 * 103mm2/s vs. 1.04
0.22 * 103mm2/s) resulting in a sensitivity of 67%
and a speciﬁcity of 60%. Furthermore, they measured
the ADC of each lymph node (ADCnode) relative to
the main tumor ADC (ADCrel) resulting in a slight
increase in sensitivity and speciﬁcity (75%/61%). In
consideration of these results they reasoned that DWI
in case of rectal cancer can demonstrate but not char-
acterize lymph nodes (13).
Another study of Heusch et al. in 2013 dealt with the
question whether ultrasound, 18F-FDG-PET/CT, or
18F-FDG-PET-MRI with DWI could improve the
accuracy of lymph node detection in the neck.
Interestingly, no diﬀerences in sensitivity, speciﬁcity,
Table 2. Distribution of malignant lymph nodes based on short
axis diameter (d).
Lymph
nodes (n)
Metastatic
lymph
nodes (n)
Prevalence
(%)
d 5mm 80 3 3.7
5mm< d 10mm 55 9 16.4
D> 10mm 14 13 92.9
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and accuracy between 18F-FDG-PET-MRI with or
without DWI were noted (52%, 97%, 92% versus
53%, 97%, 92%, respectively). Ultrasound was superior
to 18F-FDG-PET-MRI with DWI concerning nodal
staging (9 versus 12 patients). In their opinion, 18F-
FDG-PET-MRI plus DWImay not increase nodal detec-
tion and preoperative staging in patients with OSCC and
therefore the method cannot replace surgical staging of
cervical lymph nodes in the near future (16).
In 2009 Vandecaveye et al. presented their study
results on diﬀusion-weighted MRI for nodal staging of
the neck including 301 lymph nodes. Using b-values of 0
and 1000 s/mm2 they found a mean ADC of
1.19 * 103mm2/s for benign and 0.85 * 103mm2/s for
malignant lymph nodes (P< 0.0001).With a cutoﬀ value
of 0.94 103mm2/s they had sensitivity of 84%, speci-
ﬁcity of 94%, and accuracy of 91%. The false-negative
ﬁndings were ascribed to intranodal necrosis which
should according to the authors be ruled out in the
anatomic sequences before rating the DWI (14). In con-
cordance to these ﬁndings necrosis also plays an
important role in our study as six of the 11 necrotic
malignant lymph nodes presented with macroscopic
non-visible necrotic portions in the histological workup.
Looking at the behavior of the ADC values with
regard to necrosis the stadium of the necrosis at the
time of MRI examination seems to be decisive. In
terms of early necrosis the ADC value is often low
due to restricted water diﬀusion caused by intracellular
edema in the tumor cells during the transition to com-
plete necrosis with liquefaction (17,18). On the con-
trary, already liquid necrotic portions with degraded
cellular structures lead to high ADC values (13). As
long as the anatomic sequences do not allow a reliable
selection of necrotic portions within in other respects
(e.g. size) benign appearing lymph nodes, the meaning-
fulness of deﬁning an ADC cutoﬀ value for the diﬀer-
entiation of malignant and benign lymph nodes
remains questionable.
Besides necrosis, tissue cellularity, cell membrane
permeability, and extracellular matrix composition
can aﬀect ADC results (19). Consequently, several
Fig. 2. Receiver-operating characteristic (ROC) curve for the detection of metastatic lymph nodes using ADC measurements.
Fig. 3. Boxplots for the distribution of the mean ADC of the two observers for the benign (n¼ 124) and malignant (n¼ 25) lymph
nodes. Individual data are presented as circles. The dotted line indicates the found optimal threshold value.
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previous studies reported lower ADC values for malig-
nant lymph nodes compared to benign lymph nodes
(14,20). These diﬀerences could, for example, be
explained by densely packed carcinoma cell deposits
in the nodal microarchitecture which restrict the dif-
fusivity resulting in low ADCs. However, increased
ADC values in metastatic lymph nodes, as found in
our study, could mainly be caused by proliferating
tumor cells and low cellularity of metastatic tumors
(21,22).
In addition, there are strong indications that the par-
tial volume eﬀect (PVE) inﬂuences the accuracy of
Fig. 4. Inter-observer agreement for nodal ADC measurements. Bland-Altman plot depicting the mean ADC of the two observers
(x-axis) against the difference in ADC between the two observers (y-axis). The dashed line represents the mean absolute difference
(bias) in ADC between the two observers; the dotted lines represent the 95% confidence interval of the mean difference.
Fig. 5. MR images of a 52-year-old patient with histological proven OSCC. (a) Axial DWI image at b-value of 1000 s/mm2,
(b) gray-scale ADC map, and (c) contrast-enhanced axial fat-suppressed T1W image showing a right-sided lymph node in the
submandibular region (white arrow). According to morphological criteria the lymph node oval in shape with a maximum diameter of
7mm was considered to be benign. At DWI the lymph node showed a mean ADC value of 1.291 103 mm2/s, making it suspicious
for a lymph node metastasis. Histological workup revealed an infiltration of tumor cells within the lymph node tissue.
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ADC measurements to a high degree (23). Former stu-
dies dealing with brain diﬀusion tensor imaging came to
the conclusion that if the voxel size exceeds 1.5mm on
one side the accuracy of DTI measurements can be
inﬂuenced signiﬁcantly (23–25). In case of an EPI-
based DWI these observations could be transferred to
ADC measurement.
The PVE originates from the acquisition as signal
averaging had to be performed if ﬁnite-size voxels
include more than one structure. In case of neck
lymph node measurements surrounding perilymphatic
tissue as, for example, muscles or salivary gland tissue
as well as hilar vascular structures could be incorpo-
rated in the ROI if the lymph node is of small size. The
contribution of these falsiﬁed voxels to the measure-
ment inﬂuences the analysis of ADC values to an
unknown variable extent (26).
Another problem could arise from the size of the
metastases within the lymph nodes. If the zone of tumor
cell inﬁltration is small or if the inﬁltration pattern is dif-
fuse a contamination of the ADC value by the inclusion
of surrounding benign lymph node portions could occur.
Some of the limitations of the presented study need
to be taken into consideration. First, although we tried
to minimize the susceptibility artifacts by modifying the
vendor supplied sequence, in some cases image distor-
tions along the phase encoding direction could be
observed, which potentially aﬀect the ADC values mea-
sured in small lesions. This issue was already observed
by other study groups (20,27).
Second, the unbalanced distribution of malignant
and benign lymph nodes in our dataset results in a
high negative predictive value. The predictive values
are in general not independent of the setting in
which the test is used but are strongly inﬂuenced by
the prevalence (28). The negative predictive value
tends to be high when applied in a population with
a low likelihood of disease. Due to early detection of
OSCC and the infrequency of lymph node metastases
in this special type of tumor high negative predictive
values of tests can often be seen in this ﬁeld of
research (14,16).
In conclusion, our ﬁndings together with the hetero-
geneous results of previous studies point out that DWI
is of limited use in the discrimination of benign and
malignant cervical lymph nodes due to a limited sensi-
tivity and speciﬁcity. The preoperative determination of
the extent of neck dissection reclusively on the basis of
ADC measurements is thereby not recommended.
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Fig. 6. MR images of a 49-year-old patient with histological proven oral squamous cell carcinoma. (a) Axial DWI image at b-value of
1000 s/mm2, (b) gray-scale ADC map, and (c) contrast-enhanced axial fat-suppressed T1W image showing a right-sided lymph node at
the cervical region (white arrow). According to morphological criteria the lymph node oval in shape with a maximum diameter of
6mm appeared also benign. At DWI the lymph node showed a mean ADC value of 0.905 103mm2/s, indicating a non-metastatic
lymph node. In concordance to the ADC measurements histological work found no tumor cells within the lymph node.
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